Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

December 2006

December 3

Pfizer Stops All Torcetrapib Clinical Trials in Interest of Patient

December 4

King Pharmaceuticals Reports FDA Approval of New Skelaxin Label

December 5

Alimera Sciences Receives FDA Approval to Market Alaway OTC for Up To 12 Hours of Eye Itch Relief FDA Warns Five Firms To Stop Compounding Topical Anesthetic Creams

December 7

Eli Lilly and Company Submits NDA for Evista for Reduction of Invasive Eli Lilly and Company Submits New Drug Application for Evista for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women

December 8

FDA Approves Velcade (Bortezomib) for Injection for Aggressive Form of Non-Hodgkinâ€™s Lymphoma

December 11

FDA Advances Effort Against Marketed Unapproved Drugs FDA Proposes Rules Overhaul to Expand Availability of Experimental Drugs

December 13

FDA Accepts New Drug Application for Sanctura XR Submitted by Indevus Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of Omacor With a Statin Access Pharmaceuticals Receives MuGard Marketing Clearance From the FDA

December 14

FDA Approves First Generic Bupropion Hydrochloride Extended-Release Tablets

December 15

FDA Revises Labeling for Trasylol FDA Approves Drug to Treat Cyanide Poisoning Celebrex Approved to Treat Juvenile Rheumatoid Arthritis

December 18

FDA Warns of Safety Concern Regarding Rituxan in New Patient Population FDA Approves Foradil Certihaler BioSante Pharmaceuticals Receives FDA Approval of Elestrin

December 19

FDA Proposes Labeling Changes to Over-the-Counter Pain Relievers

December 20

FDA Approves Invega, a New Drug for Schizophrenia FDA Approves Colazal for Children and Teens With Mildly to Moderately Active Ulcerative Colitis

December 21

FDA Approves New Indication for Invanz

December 22

Exforge Receives US Regulatory Approval as for Patients with High Blood Pressure FDA Approves Byetta (exenatide) Injection for Expanded Combination Use

December 26

Osteoporosis Drug Gives Lasting Protection HRT Debate Continues

December 27

FDA Approves First Generic Ondansetron Tablets, Orally Disintegrating Tablets and Oral Solution Medicare's Prescription Drug Plan Enrollment Deadline Looms

December 28

Breast Cancer Treatment Drug Tykerb Slows Tumor Growth

Pharmaceutical Industry News Archive

2012

January, February

2011

January, February, March, April, May, June, July, August, September, October, November, December

2010

January, February, March, April, May, June, July, August, September, October, November, December

2009

January, February, March, April, May, June, July, August, September, October, November, December

2008

January, February, March, April, May, June, July, August, September, October, November, December

2007

January, February, March, April, May, June, July, August, September, October, November, December

2006

January, February, March, April, May, June, July, August, September, October, November, December

2005

January, February, March, April, May, June, July, August, September, October, November, December

2004

January, February, March, April, May, July, August, September, October, November, December

2003

January, February, March, April, May, June, July, August, September, October, November, December

2002

January, April, May, June, August, September, October, November, December

More News Resources

Printable Version Email Recommend Tweet Save or Share

Sign In or Register

Forgot password?

FDA Consumer Updates

More FDA Updates...

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

Get Updates by Email

Email me:

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

Copyright © 2000-2012 Drugs.com. All rights reserved.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

(web1)